MEGA Stock Overview
Manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa.
Snowflake Score | |
---|---|
Valuation | 4/6 |
Future Growth | 2/6 |
Past Performance | 3/6 |
Financial Health | 6/6 |
Dividends | 4/6 |
Mega Lifesciences Public Company Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ฿39.50 |
52 Week High | ฿46.75 |
52 Week Low | ฿34.75 |
Beta | 0.40 |
1 Month Change | -3.66% |
3 Month Change | -4.82% |
1 Year Change | -1.25% |
3 Year Change | 12.86% |
5 Year Change | 8.22% |
Change since IPO | 85.45% |
Recent News & Updates
Recent updates
Shareholder Returns
MEGA | TH Pharmaceuticals | TH Market | |
---|---|---|---|
7D | -2.5% | -1.7% | -1.2% |
1Y | -1.3% | 1.8% | -11.2% |
Return vs Industry: MEGA underperformed the TH Pharmaceuticals industry which returned 1.8% over the past year.
Return vs Market: MEGA exceeded the TH Market which returned -11.2% over the past year.
Price Volatility
MEGA volatility | |
---|---|
MEGA Average Weekly Movement | 2.5% |
Pharmaceuticals Industry Average Movement | 5.3% |
Market Average Movement | 4.2% |
10% most volatile stocks in TH Market | 8.9% |
10% least volatile stocks in TH Market | 2.2% |
Stable Share Price: MEGA has not had significant price volatility in the past 3 months.
Volatility Over Time: MEGA's weekly volatility (3%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1982 | n/a | Vivek Dhawan | www.megawecare.com |
Mega Lifesciences Public Company Limited, together with its subsidiaries, manufactures and sells health food supplements, prescription pharmaceutical products, over-the-counter products, herbal products, vitamins, and fast-moving consumer goods in Southeast Asia and Sub-Saharan Africa. The company operates in three segments: Brands, Distribution, and Original Equipment Manufacture (OEM). It provides various medicines for allergies; blood circulation and memory; bone and joint; liver and digestive; eyes, heart, and skin; pain, sleeping, well-being, herbal, and cough and colds; and vitamins, probiotics, medical and sports nutrition, as well as kids’, men’s, and women’s care products.
Mega Lifesciences Public Company Limited Fundamentals Summary
MEGA fundamental statistics | |
---|---|
Market cap | ฿34.44b |
Earnings (TTM) | ฿2.02b |
Revenue (TTM) | ฿15.72b |
17.1x
P/E Ratio2.2x
P/S RatioIs MEGA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MEGA income statement (TTM) | |
---|---|
Revenue | ฿15.72b |
Cost of Revenue | ฿8.47b |
Gross Profit | ฿7.25b |
Other Expenses | ฿5.23b |
Earnings | ฿2.02b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 13, 2024
Earnings per share (EPS) | 2.31 |
Gross Margin | 46.13% |
Net Profit Margin | 12.83% |
Debt/Equity Ratio | 0.9% |
How did MEGA perform over the long term?
See historical performance and comparison